Our Shield™ blood test gains FDA approval, ushering in a new era of colorectal cancer screening.  More Details

International
Presense


Cancer knows no boundaries, which is why our global teams are dedicated to working together to drive meaningful change.


A Global Effort

Cancer transcends borders, and so does our mission. As we partner with labs and leading cancer centers worldwide to expand access to our liquid biopsy tests, our global teams are dedicated to advancing precision oncology while maintaining our high quality and performance standards. Connect with us to learn how we’re making a significant impact on cancer care across diverse markets.

Contact to Learn More

Europe, Canada, Latin America

Guardant Health currently markets its tests in over 60 countries outside the United States, primarily through distributor relationships and direct contracts with hospitals. For more information, please visit guardanthealth.eu for Europe & Latin America, guardanthealth.ca for Canada or contact us at clientserviceseurope@guardanthealth.com.


Asia, Middle East, Africa

The World Health Organization estimates that more than half of the world’s estimated new cancer cases come from Asia, Middle East, or Africa. Please visit guardanthealthamea.com or contact us at clientservicesamea@guardanthealth.com.